Find Lorcainide manufacturers, exporters & distributors on PharmaCompass

Lorcainide

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Lopantrol, Socainide hydrochloride, Isocainide hydrochloride, Lorcainide hydrochloride [usan], Einecs 261-504-6, N-(4-chlorophenyl)-2-phenyl-n-(1-propan-2-ylpiperidin-1-ium-4-yl)acetamide;chloride

Molecular Formula

C₂₂H₂₈Cl₂N₂O

Molecular Weight

407.4 g/mol

InChI Key

FSFSWNBDCJVFGI-UHFFFAOYSA-N

1 2D Structure

Lorcainide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-(4-chlorophenyl)-2-phenyl-N-(1-propan-2-ylpiperidin-1-ium-4-yl)acetamide;chloride

2.1.2 InChI

InChI=1S/C22H27ClN2O.ClH/c1-17(2)24-14-12-21(13-15-24)25(20-10-8-19(23)9-11-20)22(26)16-18-6-4-3-5-7-18;/h3-11,17,21H,12-16H2,1-2H3;1H

2.1.3 InChI Key

FSFSWNBDCJVFGI-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C)[NH+]1CCC(CC1)N(C2=CC=C(C=C2)Cl)C(=O)CC3=CC=CC=C3.[Cl-]

2.2 Synonyms

2.2.1 MeSH Synonyms

1. 4'-chloro-n-(1-isopropyl-4-piperidyl)-2-phenylacetanilide

2. Lorcainid

3. Lorcainide

4. Lorcainide Monohydrochloride

5. R 15889

6. R15889

7. Ro 13-1042

2.2.2 Depositor-Supplied Synonyms

1. Lopantrol

2. Socainide Hydrochloride

3. Isocainide Hydrochloride

4. Lorcainide Hydrochloride [usan]

5. Einecs 261-504-6

6. N-(4-chlorophenyl)-2-phenyl-n-(1-propan-2-ylpiperidin-1-ium-4-yl)acetamide;chloride

7. Ro 13-1042

8. Lorivox

9. R 15889

10. 1t1s98onm1

11. 1313498-17-7

12. Benzeneacetamide, N-(4-chlorophenyl)-n-(1-(1-methylethyl)-4-piperidinyl)-, Monohydrochloride

13. Lorcainida Clorhidrato [spanish]

14. Lorcainida Clorhidrato

15. Unii-1t1s98onm1

16. N-(p-chlorophenyl)-n-(1-isopropylpiperidin-4-yl)phenylacetamide Hydrochloride

17. Nsc 310411

2.3 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₂₂H₂₈Cl₂N₂O
Molecular Weight	407.4 g/mol
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	5
Exact Mass	406.1578689 g/mol
Monoisotopic Mass	406.1578689 g/mol
Topological Polar Surface Area	24.8 Å²
Heavy Atom Count	27
Formal Charge	0
Complexity	433
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)

API SUPPLIERS